The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse.

Author: MaassenVanDenBrinkAntoinette, van HoogstratenWillem Sebastiaan

Paper Details 
Original Abstract of the Article :
Label="BACKGROUND" NlmCategory="BACKGROUND">The treatment of migraine is impeded by several difficulties, among which insufficient headache relief, side effects, and risk for developing medication overuse headache (MOH). Thus, new acutely acting antimigraine drugs are currently being developed, amon...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734450/

データ提供:米国国立医学図書館(NLM)

Navigating the Migraine Maze: New Drugs on the Horizon

The field of [migraine treatment] is constantly evolving, driven by the persistent search for effective and safe solutions. This research delves into the challenges of migraine management, particularly the limitations of current therapies, including insufficient pain relief, side effects, and the risk of developing [medication overuse headache]. This research explores the potential of novel antimigraine medications, such as CGRP receptor antagonists (gepants) and the 5-HT1F receptor agonist lasmiditan, offering hope for improved migraine management. The primary goal of this study was to investigate the potential for these new drugs to contribute to medication overuse headache, a crucial concern for patients. The authors discovered that the risk of developing MOH with these new drugs is currently unknown, highlighting the importance of further research in this area. This research sheds light on the evolving landscape of migraine treatment and underscores the need for continued research to ensure the safety and efficacy of new therapeutic options.

Unraveling the Mystery of Medication Overuse Headache

The findings suggest that the risk of developing MOH with these new drugs is unknown, prompting further research to assess their long-term safety. This information is critical for clinicians and patients to make informed decisions about migraine treatment. The research underscores the need for a multi-pronged approach to managing migraine, focusing on both acute and preventative strategies.

Navigating the Migraine Maze: What to Know

Remember, migraine management involves a multifaceted approach that includes lifestyle adjustments, medication, and prevention. If you are experiencing frequent or severe migraines, it is crucial to consult with a healthcare professional to determine the most appropriate treatment options for you. While new medications offer promise, careful monitoring for potential side effects and medication overuse is essential for long-term migraine management.

Dr. Camel's Conclusion

The quest for effective migraine treatments continues! This research illuminates the challenges of migraine management and offers hope for improved treatment options. It emphasizes the importance of staying informed about new developments in migraine research, seeking guidance from healthcare professionals, and taking a holistic approach to managing migraine.

Date :
  1. Date Completed 2019-08-14
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

31096904

DOI: Digital Object Identifier

PMC6734450

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.